Amyloid β oligomers induce Ca2+ dysregulation and neuronal death through activation of ionotropic glutamate receptors

Billings, 2005, Intraneuronal Aβ causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice, Neuron, 45, 675, 10.1016/j.neuron.2005.01.040

Oddo, 2006, Temporal profile of amyloid-β (Aβ) oligomerization in an in vivo model of Alzheimer disease: a link between Aβ and tau pathology, J. Biol. Chem., 281, 1599, 10.1074/jbc.M507892200

Kuo, 1996, Water-soluble Aβ (N-40, N-42) oligomers in normal and Alzheimer disease brains, J. Biol. Chem., 271, 4077, 10.1074/jbc.271.8.4077

Kayed, 2003, Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis, Science, 300, 486, 10.1126/science.1079469

Gong, 2003, Alzheimer's disease-affected brain: presence of oligomeric Aβ ligands (ADDLs) suggests a molecular basis for reversible memory loss, Proc. Natl. Acad. Sci. U.S.A., 100, 10417, 10.1073/pnas.1834302100

Lacor, 2004, Synaptic targeting by Alzheimer's-related amyloid β oligomers, J. Neurosci., 24, 10191, 10.1523/JNEUROSCI.3432-04.2004

Lue, 1999, Soluble amyloid b peptide concentration as a predictor of synaptic change in Alzheimer's disease, Am. J. Pathol., 155, 853, 10.1016/S0002-9440(10)65184-X

McLean, 1999, Soluble pool of Aβ amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease, Ann. Neurol., 46, 860, 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M

Naslund, 2000, Correlation between elevated levels of amyloid β-peptide in the brain and cognitive decline, JAMA, 283, 1571, 10.1001/jama.283.12.1571

LaFerla, 2002, Calcium dyshomeostasis and intracellular signalling in Alzheimer's disease, Nat. Rev. Neurosci., 3, 862, 10.1038/nrn960

Wang, 2000, β-Amyloid (1–42) binds to alpha 7 nicotinic acetylcholine receptor with high affinity. Implications for Alzheimer's disease pathology, J. Biol. Chem., 275, 5626, 10.1074/jbc.275.8.5626

Arispe, 2007, Aβ ion channels. Prospects for treating Alzheimer's disease with Aβ channel blockers, Biochim. Biophys. Acta-Biomembr., 1768, 1952, 10.1016/j.bbamem.2007.03.014

De Felice, 2007, Aβ oligomers induce neuronal oxidative stress through an N-methyl-d-aspartate receptor-dependent mechanism that is blocked by the Alzheimer drug memantine, J. Biol. Chem., 282, 11590, 10.1074/jbc.M607483200

Demuro, 2005, Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers, J. Biol. Chem., 280, 17294, 10.1074/jbc.M500997200

Kelly, 2006, β Amyloid-induced dynamin 1 degradation is mediated by N-methyl-d-aspartate receptors in hippocampal neurons, J. Biol. Chem., 281, 28079, 10.1074/jbc.M605081200

Deshpande, 2009, A role for synaptic zinc in activity-dependent Aβ oligomer formation and accumulation at excitatory synapses, J. Neurosci., 29, 4004, 10.1523/JNEUROSCI.5980-08.2009

Kabogo, 2008, β-amyloid-related peptides potentiate K+-evoked glutamate release from adult rat hippocampal slices, Neurobiol. Aging

Li, 2009, Soluble oligomers of amyloid β protein facilitate hippocampal long-term depression by disrupting neuronal glutamate uptake, Neuron, 62, 788, 10.1016/j.neuron.2009.05.012

Mattson, 1992, β-amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity, J. Neurosci., 12, 376, 10.1523/JNEUROSCI.12-02-00376.1992

Klein, 2002, Aβ toxicity in Alzheimer's disease: globular oligomers (ADDLs) as new vaccine and drug targets, Neurochem. Int., 41, 345, 10.1016/S0197-0186(02)00050-5

Gottlieb, 2006, Neuroprotection by two polyphenols following excitotoxicity and experimental ischemia, Neurobiol. Dis., 23, 374, 10.1016/j.nbd.2006.03.017

Grynkiewicz, 1985, A new generation of Ca2+ indicators with greatly improved fluorescence properties, J. Biol. Chem., 260, 3440, 10.1016/S0021-9258(19)83641-4

Hajnóczky, 1995, Decoding of cytosolic calcium oscillations in the mitochondria, Cell, 82, 415, 10.1016/0092-8674(95)90430-1

Pozzo-Miller, 1994, Spontaneous pyramidal cell death in organotypic slice cultures from rat hippocampus is prevented by glutamate receptor antagonists, Neuroscience, 63, 471, 10.1016/0306-4522(94)90544-4

Shankar, 2007, Natural oligomers of the Alzheimer amyloid-β protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signalling pathway, J. Neurosci., 27, 2866, 10.1523/JNEUROSCI.4970-06.2007

Parameshwaran, 2007, Amyloid beta-peptide Aβ(1–42) but not Aβ(1–40) attenuates synaptic AMPA receptor function, Synapse, 61, 367, 10.1002/syn.20386

Sanz-Blasco, 2008, Mitochondrial Ca2+ overload underlies Aβ oligomers neurotoxicity providing an unexpected mechanism of neuroprotection by NSAIDs, PLoS ONE, 3, e2718, 10.1371/journal.pone.0002718

De Lacoste, 1993, The role of cortical connectivity in Alzheimer's disease pathogenesis: a review and model system, Neurobiol. Aging, 14, 1, 10.1016/0197-4580(93)90015-4

Kluge, 1998, Tracing of the entorhinal–hippocampal pathway in vitro, Hippocampus, 8, 57, 10.1002/(SICI)1098-1063(1998)8:1<57::AID-HIPO6>3.0.CO;2-4

Szegedi, 2005, Divergent effects of Aβ 1-42 on ionotropic glutamate receptor-mediated responses in CA1 neurons in vivo, Brain Res., 1062, 120, 10.1016/j.brainres.2005.09.014

Blanchard, 2004, Efficient reversal of Alzheimer's disease fibril formation and elimination of neurotoxicity by a small molecule, Proc. Natl. Acad. Sci. U.S.A., 101, 14326, 10.1073/pnas.0405941101

Tozaki, 2002, The inhibitory and facilitatory actions of amyloid-β peptides on nicotinic ACh receptors and AMPA receptors, Biochem. Biophys. Res. Commun., 294, 42, 10.1016/S0006-291X(02)00429-1

Atlante, 2001, Glutamate neurotoxicity, oxidative stress and mitochondria, FEBS Lett., 497, 1, 10.1016/S0014-5793(01)02437-1

Nicholls, 2000, Mitochondria and neuronal survival, Physiol. Rev., 80, 315, 10.1152/physrev.2000.80.1.315

Butterfield, 2003, The glutamatergic system and Alzheimer's disease: therapeutic implications, CNS Drugs, 17, 641, 10.2165/00023210-200317090-00004

Cacabelos, 1999, The glutamatergic system and neurodegeneration in dementia: preventive strategies in Alzheimer's disease, Int. J. Geriatr. Psych., 14, 3, 10.1002/(SICI)1099-1166(199901)14:1<3::AID-GPS897>3.0.CO;2-7

Francis, 2003, Glutamatergic systems in Alzheimer's disease, Int. J. Geriatr. Psych., 18, S15, 10.1002/gps.934

Mattson, 2003, Neuronal and glial calcium signaling in Alzheimer's disease, Cell Calcium, 34, 385, 10.1016/S0143-4160(03)00128-3

Hynd, 2004, Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer's disease, Neurochem. Int., 45, 583, 10.1016/j.neuint.2004.03.007

Verkhratsky, 2007, NMDA Receptors in glia, Neuroscientist, 13, 28, 10.1177/1073858406294270

Matute, 2007, Excitotoxic damage to white matter, J. Anat., 210, 693, 10.1111/j.1469-7580.2007.00733.x

Bakiri, 2009, Glutamatergic signaling in the brain's white matter, Neuroscience, 158, 266, 10.1016/j.neuroscience.2008.01.015

Rodríguez, 2009, Astroglia in dementia and Alzheimer's disease, Cell Death Differ., 16, 378, 10.1038/cdd.2008.172

Heneka, 2009, Neuroglia in neurodegeneration, Brain Res. Rev.